Target intelligence / Profile preview

MKS transition zone complex subunit 1 (MKS1)

Target
MKS1
Molecular classification
Other (Ciliary basal body and transition zone protein)
01

Overview

MKS transition zone complex subunit 1 (MKS1) is a protein localized to the basal body and transition zone of the primary cilium in eukaryotic cells[1][2][7]. MKS1 is essential for the biogenesis and structural maintenance of the primary cilium, a microtubule-based organelle involved in signaling and development[1][3]. MKS1 is a core component of the Meckel-Gruber syndrome (MKS) module, a multi-protein complex at the ciliary transition zone that functions as a gating structure, regulating protein and lipid movement into the cilium and facilitating the docking of the basal body to the plasma membrane[1][5]. Mutations in the MKS1 gene cause Meckel syndrome (a lethal congenital ciliopathy with CNS, renal, and hepatic malformations) and Bardet-Biedl syndrome (a multisystem disorder), demonstrating MKS1’s key role in mammalian development and signaling[1][2][3][4][5][7]. MKS1 also interacts functionally with the BBSome and intraflagellar transport (IFT) complexes, coordinating trafficking of signaling molecules such as transmembrane receptors to the cilium, and supporting Hedgehog pathway signaling[4][5]. Complete disruption of MKS1 leads to loss of cilia formation and severe developmental abnormalities[1][2][3][5]. Currently, no approved therapeutic drugs target MKS1 directly, but its gene and protein functions are exploited as biomarkers for diagnosing and understanding ciliopathies[1][7].

Other names
Meckel syndrome type 1 proteinPOC12 centriolar protein homologBBS13JBTS28FLJ20345Meckel syndrome type 1tectonic-like complex member MKS1POC12
02

Biological functions

CiliogenesisCiliary assembly and maintenanceProtein trafficking within the ciliumRegulation of Hedgehog signaling pathway
03

Disease associations

Ciliopathy (Meckel syndrome)Bardet–Biedl syndromeJoubert syndrome (related proteins)
04

Safety considerations

Potential for severe congenital disorders with complete loss of function[1][6]
05

Biomarkers

Mutations in MKS1 gene used as biomarker in Meckel syndrome and Bardet–Biedl syndrome[1]

Beyond the preview

Go deeper on MKS transition zone complex subunit 1 (MKS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MKS transition zone complex subunit 1 (MKS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call